Form 4: Third Harmonic Bio Executive Julie Person Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Julie Person, Chief Administrative Officer of Third Harmonic Bio, exercised stock options and sold 10,000 shares of common stock on June 26, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On June 26, 2024, Julie Person, the Chief Administrative Officer of Third Harmonic Bio, exercised an option to purchase 10,000 shares of common stock at a price of $4.20 per share.
- Simultaneously, Ms. Person sold 10,000 shares of common stock at a weighted average price of $12.4569 per share, with individual sales prices ranging from $12.00 to $12.90.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on March 27, 2024.
- Following these transactions, Ms. Person no longer directly owns any shares of Third Harmonic Bio common stock, but continues to hold options for 165,962 shares.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders. The use of a 10b5-1 plan suggests the insider's transactions were pre-planned and not based on inside information at the time of the trades.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| March 27, 2024 | Date of adoption of Rule 10b5-1 trading plan |
| June 20, 2023 | Initial vesting date for 25% of employee option grant shares |
| June 26, 2024 | Date of stock option exercise and share sale |
| June 28, 2024 | Date of filing of Form 4 |
| July 27, 2032 | Expiration date of employee option grant |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.